Latest news
TNX-103 Misses Primary Endpoint in Phase 3 LEVEL PH-HFpEF Trial - HCPLiveHCPLive · Mon, 10 Aug 2026 15:03:24 GMTOrion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:36:28 GMTREG - Oxford BioDynamics - Fundraising, Posting of Circular & Notice of GM - TradingViewTradingView · Mon, 10 Aug 2026 13:00:00 GMTNotice of Extraordinary General Meeting of Shareholders of Kaspi.kz - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:57 GMTTransactions in connection with share buyback programme - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:55 GMTDimensional Fund Advisors Ltd. : Form 8.3 - HARWORTH GROUP PLC - Ordinary Shares - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:54 GMTInstinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:52 GMTQuantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis: - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:51 GMT